These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 20670961

  • 1. Development of cancer cooperative groups in Japan.
    Fukuda H.
    Jpn J Clin Oncol; 2010 Sep; 40(9):881-90. PubMed ID: 20670961
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials].
    Shimoyama M, Tajima K.
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2507-18. PubMed ID: 8279849
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ, McKinney MM, Carpenter WR.
    Cancer; 2006 Jan 01; 106(1):180-7. PubMed ID: 16333855
    [Abstract] [Full Text] [Related]

  • 9. [Post launch studies].
    Akaza H, Ohashi Y, Shimada Y, Ikeda T, Saijo N, Isonishi S, Hirao Y, Tsuruo T, Tsukagoshi S, Sone S, Nakamura S, Kato M, Mikami O, von Euler M, Blackledge G, Milsted B, Vose B.
    Gan To Kagaku Ryoho; 2002 Nov 01; 29(11):2037-48. PubMed ID: 12465411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
    Dilts DM, Sandler AB, Baker M, Cheng SK, George SL, Karas KS, McGuire S, Menon GS, Reusch J, Sawyer D, Scoggins M, Wu A, Zhou K, Schilsky RL, Case of Cancer and Leukemia Group B.
    J Clin Oncol; 2006 Oct 01; 24(28):4553-7. PubMed ID: 17008694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
    Ekimoto H.
    Gan To Kagaku Ryoho; 1997 Jan 01; 24(2):229-37. PubMed ID: 9030236
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Need to establish academic research organization for cancer clinical trial and clinical research system having clinical investigators and study coordinators, with special reference to promotion of medical and life science research policy].
    Shimoyama M.
    Gan To Kagaku Ryoho; 1999 Jan 01; 26(2 Suppl):235-46. PubMed ID: 9987525
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.
    Steensma DP.
    J Clin Oncol; 2007 Mar 20; 25(9):1148; author reply 1148-9. PubMed ID: 17369584
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.